---
import Layout from "../layouts/Layout.astro";
import CTA from "../components/CTA.astro";
import InternalNavigation from "../components/InternalNavigation.astro";
import CaseFileModal from "../components/Case-Files/CaseFileModal.astro";

const internalNavLinks = [
  { href: "hpp-definition", label: "HPP Definition", active: true },
  {
    href: "hpp-multisystemic",
    label: "Multisystemic Symptoms and Disease Burden",
  },
  { href: "hpp-prevalence", label: "Prevalence of HPP" },
];
---

<Layout title="HPP Profile" pageClass="hpp__profile" showISI={false}>
  {internalNavLinks && <InternalNavigation items={internalNavLinks} />}

  <!-- HPP Definition -->
  <section id="hpp-definition" class="profiling-hypophostasia section">
    <div class="hpp__profile__red-string-bg">
      <div class="wrapper hpp__profile__content">
        <h2 class="hpp__profile__main-title color--red text--uppercase">
          Profiling Hypophosphatasia (HPP)
        </h2>
        <h3 class="hpp__profile__sub-title color--white">
          Take a look at the case file of hypophosphatasia to learn how it stays
          hidden and how it may be causing harm to your patients
        </h3>
        <p
          class="hpp__profile__paragraph hpp__profile__paragraph--sub color--white"
        >
          Hypophosphatasia is an inherited, multisystemic, rare metabolic
          disorder characterized by persistently low age- and sex- adjusted
          alkaline phosphatase (ALP) activity that may progress over time.<sup
            class="color--white">1,2</sup
          >
        </p>
      </div>

      <div class="hpp__profile__image-container">
        <h2 class="hpp__profile__hidden-title">11A0763</h2>
        <picture>
          <source
            srcset="/assets/images/hpp-profile/hpp-profile.png"
            media="(min-width: 700px)"
          />
          <img
            class="hpp__profile__image"
            src="/assets/images/hpp-profile/hpp-profile-mb.png"
            alt="HPP Profile"
          />
        </picture>
      </div>

      <div class="hpp__profile__red-frame-disclaimer">
        <p
          class="hpp__profile__paragraph hpp__profile__paragraph--sub hpp__profile__red-frame-disclaimer--content color--white text--center"
        >
          Hypophosphatasia may become debilitating and can cause damage to
          <span class="hpp__profile__red-frame-disclaimer--text-red"
            >multiple systems</span
          > in the body beyond the skeletal system.<sup>3-5</sup>
        </p>
      </div>
    </div>
  </section>

  <!-- Multisystemic Symptoms and Disease Burden -->
  <section id="hpp-multisystemic" class="section hpp-multisystemic">
    <h2 class="wrapper hpp__profile__title hpp__profile__title--desktop">
      How hypophosphatasia CAN cause harm
    </h2>
    <article class="hpp-multisystemic__tabs">
      <ul role="tablist" class="hpp-multisystemic__tabs--nav">
        <li role="presentation" class="hpp-multisystemic__tabs--nav-item">
          <a href="#multisystemic1" role="tab" id="tab1" aria-selected="true"
            >Adults</a
          >
        </li>
        <li role="presentation" class="hpp-multisystemic__tabs--nav-item">
          <a href="#multisystemic2" role="tab" id="tab2" tabindex="-1"
            >Children/Adolescents</a
          >
        </li>
        <li role="presentation" class="hpp-multisystemic__tabs--nav-item">
          <a href="#multisystemic3" role="tab" id="tab3" tabindex="-1"
            >Neonates/Infants</a
          >
        </li>
      </ul>

      <div class="wrapper">
        <h2 class="hpp__profile__title hpp__profile__title--mobile">
          How hypophosphatasia CAN cause harm
        </h2>

        <div class="hpp-multisystemic__select">
          <select
            name="hpp-multisystemic-select"
            id="hpp-multisystemic-select"
            class="hpp-multisystemic__select--input"
          >
            <option value="multisystemic1">Adults</option>
            <option value="multisystemic2">Children/Adolescents</option>
            <option value="multisystemic3">Neonates/Infants</option>
          </select>
        </div>
      </div>

      <!-- Tab adults content -->
      <section
        id="multisystemic1"
        data-target="multisystemic1"
        role="tabpanel"
        aria-labelledby="tab1"
        aria-hidden="false"
        tabindex="-1"
      >
        <div class="hpp-multisystemic__bg-paper">
          <article class="wrapper hpp-multisystemic__definition">
            <div class="hpp-multisystemic__col">
              <p class="hpp-multisystemic__definition--text">
                <span class="hpp-multisystemic__definition--text-red"
                  >Adults with hypophosphatasia</span
                > may experience a full spectrum of symptoms. In addition to the
                typical skeletal effects, pain and muscular/metabolic manifestations
                are also common in adults with hypophosphatasia, regardless of age
                of onset.<sup>6,7*</sup>
              </p>
              <div class="wrapper">
                <span class="wrapper hpp-multisystemic__definition--condition">
                  *Adults may have a history of childhood symptoms.<sup>6</sup>
                </span>
              </div>

              <h3
                class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title-desktop"
              >
                Studies of adult patients found:
              </h3>
            </div>
            <div class="hpp-multisystemic__col">
              <div class="hpp-multisystemic__definition--media">
                <picture>
                  <img
                    class="hpp-multisystemic__definition--photo-bg"
                    src="/assets/images/hpp-profile/patient-photo--bg.png"
                    alt="Patient adults"
                  />
                </picture>

                <picture>
                  <img
                    class="hpp-multisystemic__definition--photo"
                    src="/assets/images/hpp-profile/patient-photo.png"
                    alt="Patient adults"
                  />
                </picture>

                <button
                  class="button button--custom-bg case-files-modal-trigger"
                  >View Patient case files</button
                >
              </div>
            </div>
          </article>

          <article class="wrapper hpp-multisystemic__studies">
            <h3
              class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title-mobile"
            >
              Studies of adult patients found:
            </h3>
            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">95%</h2>
              <p class="hpp-multisystemic__study--text">
                of patients reported pain and <span
                  class="hpp-multisystemic__study--text-bold hpp-multisystemic__study--text-red"
                  >76%</span
                > said <span class="hpp-multisystemic__study--text-bold"
                  >bone pain</span
                > was severe enough to limit activity<sup>7†</sup>
              </p>
            </div>

            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">74%</h2>
              <p class="hpp-multisystemic__study--text">
                of patients reported <span
                  class="hpp-multisystemic__study--text-bold"
                  >inability to climb stairs</span
                > and <span
                  class="hpp-multisystemic__study--text-bold hpp-multisystemic__study--text-red"
                  >81%</span
                > reported <span class="hpp-multisystemic__study--text-bold"
                  >inability to descend stairs
                </span><sup>7†</sup>
              </p>
            </div>

            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">78%</h2>
              <p class="hpp-multisystemic__study--text">
                had <span class="hpp-multisystemic__study--text-bold"
                  >difficulty walking</span
                ><sup>7†</sup>
              </p>
            </div>

            <div
              class="hpp-multisystemic__study hpp-multisystemic__study--line"
            >
              <h2 class="hpp-multisystemic__study--percentage">&gt50%</h2>
              <p class="hpp-multisystemic__study--text">
                A separate study of patients with hypophosphatasia reported
                their health problems <span
                  class="hpp-multisystemic__study--text-bold"
                >
                  negatively affected their physical and mental functioning
                </span><sup>8‡</sup>
              </p>
              <img
                src="/assets/images/hpp-profile/study-red-line.png"
                alt="Study red line"
                class="hpp-multisystemic__study--red-line-img"
              />
            </div>
          </article>

          <p
            class="wrapper hpp-multisystemic__condition hpp-multisystemic__condition--dagger"
          >
            Data collected from patients and caregivers via 2 survey instruments
            (web-based and phone interviews) to evaluate patient-reported
            symptomatology and burden of disease of hypophosphatasia (N=125).
            The majority of patients in this study (67%) reported pediatric
            onset of hypophosphatasia symptoms. Of patients reporting
            adult-onset hypophosphatasia (27%), 50% (17/34) reported history or
            surgeries, suggestive of pediatric onset of symptoms.<sup>7</sup>
          </p>

          <p
            class="wrapper hpp-multisystemic__condition hpp-multisystemic__condition--double-dagger"
          >
            Data from the Global HPP Registry, an observational, longitudinal,
            multinational, long-term study of patients ≥18 years with a
            confirmed diagnosis of hypophosphatasia using physician-entered
            medical record data from consenting patients (N=304). Of the 304
            adults, 33% (~100 patients) had pediatric-onset HPP.<sup>8</sup>
          </p>

          <article class="wrapper hpp-multisystemic__impact">
            <h3 class="hpp-multisystemic__impact--title">
              The multisystemic impact of hypophosphatasia
            </h3>

            <picture>
              <source
                media="(min-width: 769px)"
                srcset="/assets/images/hpp-profile/fpo-img-dk.png"
              />
              <img
                style="margin-bottom: 2rem;"
                src="/assets/images/hpp-profile/fpo-img.png"
                alt="FPO IMAGE"
              />
            </picture>
          </article>

          <article class="hpp-multisystemic__report">
            <h2 class="wrapper hpp-multisystemic__report--title">
              Systems of the body that adults with HPP report signs/symptoms in<sup
                >6</sup
              >:
            </h2>

            <picture>
              <source
                media="(min-width: 769px)"
                srcset="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-8m--desktop.png"
              />
              <img
                class="hpp-multisystemic__report--chart"
                src="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-8m.png"
                alt="FPO IMAGE"
              />
            </picture>
            <p class="hpp-multisystemic__report--chart--foot">
              Percent of patients
            </p>

            <div
              class="hpp-multisystemic__study hpp-multisystemic__study--full-width"
            >
              <p class="hpp-multisystemic__study--head-text">
                Observational, multinational, prospective Global HPP Registry
                study conducted in adults (n=148; ≥18 years) from January 2015
                to September 2017.<sup>6</sup>
              </p>
              <h2 class="hpp-multisystemic__study--percentage">12%</h2>
              <p class="hpp-multisystemic__study--text">
                of adult patients with hypophosphatasia experienced <span
                  class="hpp-multisystemic__study--text-bold"
                  >neurologic symptoms</span
                ><sup>6</sup>
              </p>
            </div>

            <h2 class="wrapper hpp-multisystemic__report--title">
              A retrospective chart review studied the prevalence of common
              neurologic symptoms associated with hypophosphatasia19<sup>a</sup>
            </h2>

            <div class="wrapper">
              <picture>
                <source
                  media="(min-width: 769px)"
                  srcset="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-9m--desktop.png"
                />
                <img
                  class="hpp-multisystemic__report--chart"
                  src="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-9m.png"
                  alt="FPO IMAGE"
                />
              </picture>
            </div>

            <p class="wrapper hpp-multisystemic__report--content">
              <sup>a</sup> Prevalence of neurologic symptoms in adults with hypophosphatasia
              (N=82) compared with the general US population.<sup>19</sup>
            </p>

            <h2 class="wrapper hpp__profile__title hpp__profile__title--blue">
              Hypophosphatasia CAN CAUSE INCREASING HARM
            </h2>

            <p class="wrapper hpp-multisystemic__report--content--harm">
              It’s vital to consider that current symptom presentation may not
              accurately represent the degree of disease progression. Patients
              with hypophosphatasia can experience a wide range of unexplained
              and debilitating symptoms that result in a frustrating journey to
              find relief. These clinical manifestations can change and
              accumulate, reflecting disease evolution and progression over
              time.<sup>1,6,8,19-22</sup>
            </p>
          </article>
        </div>
      </section>

      <!-- Tab children content -->
      <section
        id="multisystemic2"
        data-target="multisystemic2"
        role="tabpanel"
        aria-labelledby="tab2"
        aria-hidden="true"
        tabindex="-1"
        hidden
      >
        <div class="hpp-multisystemic__bg-paper">
          <article class="wrapper hpp-multisystemic__definition">
            <div class="hpp-multisystemic__col">
              <p class="hpp-multisystemic__definition--text">
                <span class="hpp-multisystemic__definition--text-red"
                  >Children and adolescents with hypophosphatasia</span
                > can experience a wide variety of multisystemic manifestations and
                behavioral challenges that impact their quality of life (QoL).6
              </p>
              <p class="hpp-multisystemic__definition--text">
                Clinically meaningful impairment in children’s pain, sleep, and
                mood was reported in one study using parent ratings.*
              </p>

              <span class="hpp-multisystemic__definition--condition">
                *Adults may have a history of childhood symptoms.
              </span>

              <h3
                class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title--no-line hpp-multisystemic__definition--title-desktop"
              >
                A study of patients/caregivers of children with hypophosphatasia
                showed:
              </h3>
            </div>
            <div class="hpp-multisystemic__col">
              <div class="hpp-multisystemic__definition--media">
                <picture>
                  <img
                    class="hpp-multisystemic__definition--photo"
                    src="/assets/images/hpp-profile/patient-photo-adolescents.png"
                    alt="Patient adults"
                  />
                </picture>

                <button
                  class="button button--custom-bg case-files-modal-trigger"
                  >View Patient case files</button
                >
              </div>
            </div>
          </article>

          <article class="wrapper hpp-multisystemic__studies">
            <h3
              class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title-mobile"
            >
              A study of patients/caregivers of children with hypophosphatasia
              showed:
            </h3>
            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">50%</h2>
              <p class="hpp-multisystemic__study--text">
                (15/30) of children had<strong>
                  clinically meaningful impairment</strong
                > in overall QoL<sup>6</sup>
              </p>
            </div>

            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">57%</h2>
              <p class="hpp-multisystemic__study--text">
                (17/30) of the children were classified as <strong
                  >poor sleepers<sup>6</sup></strong
                >
              </p>
            </div>

            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">29%</h2>
              <p class="hpp-multisystemic__study--text">
                (7/24) of school-aged children experienced higher than average
                levels of <strong
                  >pain that interfered with daily activities<sup>6*</sup>
                </strong>
              </p>
            </div>
          </article>

          <p class="wrapper hpp-multisystemic__condition">
            *Data from a cross-sectional study, reported by parents of 30
            eligible children with HPP (aged 3 to 16.6 years).6
          </p>

          <article class="wrapper hpp-multisystemic__impact">
            <h3 class="hpp-multisystemic__impact--title">
              The multisystemic impact of hypophosphatasia
            </h3>

            <picture>
              <source
                media="(min-width: 769px)"
                srcset="/assets/images/hpp-profile/fpo-img-dk.png"
              />
              <img
                style="margin-bottom: 2rem;"
                src="/assets/images/hpp-profile/fpo-img.png"
                alt="FPO IMAGE"
              />
            </picture>
          </article>

          <article class="hpp-multisystemic__report">
            <h2 class="wrapper hpp-multisystemic__report--title">
              Systems of the body that children with HPP report signs/symptoms
              in <sup>13</sup>:
            </h2>

            <picture>
              <source
                media="(min-width: 769px)"
                srcset="/assets/images/hpp-profile/adolescents-signs-and-symptoms-chart--desktop.png"
              />
              <img
                class="hpp-multisystemic__report--chart"
                src="/assets/images/hpp-profile/adolescents-signs-and-symptoms-chart.png"
                alt="FPO IMAGE"
              />
            </picture>

            <p>
              Multinational, observational, prospective Global Hypophosphatasia
              Registry study conducted in children (n=121; &lt 18 years) from
              January 2015 to September 2017.
            </p>

            <p><sup>a</sup>Excludes patients aged &lt 2 years at enrollment.</p>

            <p>
              <sup>b</sup>Excludes patients aged &lt 6 months at enrollment.
            </p>

            <div
              class="hpp-multisystemic__study hpp-multisystemic__study--full-width"
            >
              <h2 class="hpp-multisystemic__study--percentage">~27%</h2>
              <p class="hpp-multisystemic__study--text">
                of children and adolescents with hypophosphatasia exhibited
                neurologic symptoms<sup>13</sup>
              </p>
            </div>

            <h2 class="wrapper hpp__profile__title hpp__profile__title--blue">
              Hypophosphatasia CAN CAUSE INCREASING HARM
            </h2>

            <p class="wrapper hpp-multisystemic__report--content--harm">
              It’s vital to consider that current symptom presentation may not
              accurately represent the degree of disease progression. Patients
              with hypophosphatasia can experience a wide range of unexplained
              and debilitating symptoms that result in a frustrating journey to
              find relief. These clinical manifestations can change and
              accumulate, reflecting disease evolution and progression over
              time.<sup>1,6,7,13,14,22,23</sup>
            </p>
          </article>
        </div>
      </section>

      <!-- Tab neonates/infants content -->
      <section
        id="multisystemic3"
        data-target="multisystemic3"
        role="tabpanel"
        aria-labelledby="tab3"
        aria-hidden="true"
        tabindex="-1"
        hidden
      >
        <div class="hpp-multisystemic__bg-paper">
          <article class="wrapper hpp-multisystemic__definition">
            <div class="hpp-multisystemic__col">
              <p class="hpp-multisystemic__definition--text">
                <span class="hpp-multisystemic__definition--text-red"
                  >Neonates and infants with hypophosphatasia
                </span>
                have a high risk of mortality and failure to thrive, making early
                and accurate diagnosis critical. <sup>1,6-8</sup>
              </p>

              <h3
                class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title-desktop"
              >
                A study of patients/caregivers of infants with hypophosphatasia
                showed:
              </h3>
            </div>
            <div class="hpp-multisystemic__col">
              <div class="hpp-multisystemic__definition--media">
                <picture>
                  <img
                    class="hpp-multisystemic__definition--photo"
                    src="/assets/images/hpp-profile/patient-photo-infants.png"
                    alt="Patient adults"
                  />
                </picture>

                <button
                  class="button button--custom-bg case-files-modal-trigger"
                  >View Patient case files</button
                >
              </div>
            </div>
          </article>

          <article class="wrapper hpp-multisystemic__studies">
            <h3
              class="hpp-multisystemic__definition--title hpp-multisystemic__definition--title-mobile"
            >
              A study of patients/caregivers of infants with hypophosphatasia
              showed:
            </h3>
            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">73%</h2>
              <p class="hpp-multisystemic__study--text">
                of untreated cases of neonatal and infantile hypophosphatasia
                were <span class="hpp-multisystemic__study--text-bold"></span>
                fatal before the age of 5.
              </p><span
                class="hpp-multisystemic__study--text-bold hpp-multisystemic__study--text-red"
              >
                58%</span
              > of cases were fatal by 1 year of age*
            </div>
            <div class="hpp-multisystemic__study">
              <h2 class="hpp-multisystemic__study--percentage">64%</h2>
              <p class="hpp-multisystemic__study--text">
                <span class="hpp-multisystemic__study--text-bold"
                  >required respiratory support,
                </span> most commonly invasive ventilation.
                <span
                  class="hpp-multisystemic__study--text-bold hpp-multisystemic__study--text-red"
                  >95%</span
                > of cases requiring invasive ventilation were fatal*
              </p>
            </div>
          </article>

          <p
            class="wrapper hpp-multisystemic__condition hpp-multisystemic__condition--dagger"
          >
            *Data from a multinational, noninterventional, retrospective chart
            review study designed to understand the natural history of 48
            patients ≤5 years of age with severe perinatal- and infantile-onset
            hypophosphatasia.
          </p>

          <h2>Overall survival</h2>

          <picture>
            <source
              media="(min-width: 769px)"
              srcset="/assets/images/hpp-profile/overall-survival-chart--dk.png"
            />
            <img
              style="margin-bottom: 2rem;"
              src="/assets/images/hpp-profile/overall-survival-chart.png"
              alt="Overall survival"
            />
          </picture>

          <p>
            Adapted from Whyte M, et al. Poster presented at: Pediatric Academic
            Societies and Asian Society for Pediatric Research Joint Meeting;
            May 3-6, 2014; Vancouver, BC, Canada.
          </p>

          <article class="hpp-multisystemic__curiosities">
            <div class="hpp-multisystemic__curiositie">
              <img
                class="hpp-multisystemic__curiositie--icon"
                src="/assets/images/hpp-profile/icons/icon_1.png"
                alt="Respiratory failure"
              />
              <p class="hpp-multisystemic__curiositie--text">
                <span class="hpp-multisystemic__curiositie--text--red"
                  >Respiratory failure</span
                > is the most common cause of death in neonates and infants with
                hypophosphatasia<sup>1,6</sup>
              </p>
            </div>
            <div class="hpp-multisystemic__curiositie">
              <img
                class="hpp-multisystemic__curiositie--icon"
                src="/assets/images/hpp-profile/icons/icon_2.png"
                alt="Infants experience rickets-like chest deformities"
              />
              <p class="hpp-multisystemic__curiositie--text">
                Infants often experience rickets-like chest deformity,
                fractures, vitamin B6-responsive seizures, craniosynostosis, and
                failure to thrive<sup>1,8</sup>
              </p>
            </div>
            <div class="hpp-multisystemic__curiositie">
              <img
                class="hpp-multisystemic__curiositie--icon"
                src="/assets/images/hpp-profile/icons/icon_3.png"
                alt="Skeletal and other multisystemic complications"
              />
              <p class="hpp-multisystemic__curiositie--text">
                Skeletal and other multisystemic complications can place
                significant functional <span
                  class="hpp-multisystemic__curiositie--text--red"
                  >burden on patients immediately or later in life<sup
                    >1,9,10</sup
                  ></span
                >
              </p>
            </div>
            <div class="hpp-multisystemic__curiositie">
              <img
                src="/assets/images/hpp-profile/icons/icon_4.png"
                class="hpp-multisystemic__curiositie--icon"
                alt="Seizures commonly occur in infants with hypophosphatasia"
              />
              <p class="hpp-multisystemic__curiositie--text">
                Seizures commonly occur in infants with hypophosphatasia due to
                altered vitamin B6 metabolism, which is not observed in children
                or adults with hypophosphatasia<sup>10</sup>
              </p>
            </div>
          </article>

          <article class="hpp-multisystemic__report">
            <h2 class="wrapper hpp-multisystemic__report--title">
              Systems of the body that adults with HPP report signs/symptoms in<sup
                >6</sup
              >:
            </h2>

            <picture>
              <source
                media="(min-width: 769px)"
                srcset="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-8m--desktop.png"
              />
              <img
                class="hpp-multisystemic__report--chart"
                src="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-8m.png"
                alt="FPO IMAGE"
              />
            </picture>
            <p class="hpp-multisystemic__report--chart--foot">
              Percent of patients
            </p>

            <div
              class="hpp-multisystemic__study hpp-multisystemic__study--full-width"
            >
              <p class="hpp-multisystemic__study--head-text">
                Observational, multinational, prospective Global HPP Registry
                study conducted in adults (n=148; ≥18 years) from January 2015
                to September 2017.<sup>6</sup>
              </p>
              <h2 class="hpp-multisystemic__study--percentage">12%</h2>
              <p class="hpp-multisystemic__study--text">
                of adult patients with hypophosphatasia experienced <span
                  class="hpp-multisystemic__study--text-bold"
                  >neurologic symptoms</span
                ><sup>6</sup>
              </p>
            </div>

            <h2 class="wrapper hpp-multisystemic__report--title">
              A retrospective chart review studied the prevalence of common
              neurologic symptoms associated with hypophosphatasia19<sup>a</sup>
            </h2>

            <div class="wrapper">
              <picture>
                <source
                  media="(min-width: 769px)"
                  srcset="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-9m--desktop.png"
                />
                <img
                  class="hpp-multisystemic__report--chart"
                  src="/assets/images/hpp-profile/adult-signs-and-symptoms-chart-9m.png"
                  alt="FPO IMAGE"
                />
              </picture>
            </div>

            <p class="wrapper hpp-multisystemic__report--content">
              <sup>a</sup> Prevalence of neurologic symptoms in adults with hypophosphatasia
              (N=82) compared with the general US population.<sup>19</sup>
            </p>

            <h2 class="wrapper hpp__profile__title hpp__profile__title--blue">
              Hypophosphatasia CAN CAUSE INCREASING HARM
            </h2>

            <p class="wrapper hpp-multisystemic__report--content--harm">
              It’s vital to consider that current symptom presentation may not
              accurately represent the degree of disease progression. Patients
              with hypophosphatasia can experience a wide range of unexplained
              and debilitating symptoms that result in a frustrating journey to
              find relief. These clinical manifestations can change and
              accumulate, reflecting disease evolution and progression over
              time.<sup>1,6,8,19-22</sup>
            </p>
          </article>
        </div>
      </section>
    </article>
  </section>
</Layout>

<CaseFileModal />

<!-- Prevalence of HPP -->
<section id="hpp-prevalence" class="section">
  <!-- HPP Patients charts -->
  <div class="hpp-patients__red-string">
    <picture>
      <img
        class="hpp-patients__red-pin"
        src="/assets/images/hpp-profile/pin.png"
        alt="Pin"
      />
    </picture>
    <p class="wrapper hpp-patients__disclaimer">
      Reduced alkaline phosphatase levels during childhood may affect peak bone
      mass later in life<sup>23,24</sup>
    </p>

    <span class="hpp-patients__red-string1"></span>
    <span class="hpp-patients__red-string2"></span>
  </div>

  <div class="wrapper hpp-patients__section">
    <div class="hpp-patients__section--bg-white">
      <p class="hpp-patients__section__disclaimer--dk">
        Reduced alkaline phosphatase levels during childhood may affect <span
          >peak bone mass later in life <sup>23,24</sup></span
        >
      </p>
      <div class="wrapper">
        <h5 class="hpp-patients__section__title">
          Percent of patients with hypophosphatasia fractures
        </h5>

        <div class="hpp-patients__section__chart">
          <!-- Desktop chart -->
          <picture>
            <img
              class="hpp-patients__section__image"
              src="/assets/images/hpp-profile/hpp-patients-chart.png"
              alt="HPP Profile"
            />
          </picture>

          <!-- Mobile chart -->
          <div class="hpp-patients__section__chart--mb">
            <img
              class="hpp-patients__section__image--mb"
              src="/assets/images/hpp-profile/chart1-mb.png"
              alt="HPP Profile"
            />
            <p class="hpp-patients__section__text-chart">
              Infants and young children (≤5 years)<sup>25a</sup>
            </p>
            <img
              class="hpp-patients__section__image--mb"
              src="/assets/images/hpp-profile/chart2-mb.png"
              alt="HPP Profile"
            />
            <p class="hpp-patients__section__text-chart">
              Children and adolescents (5-15 years)<sup>26b</sup>
            </p>
            <img
              class="hpp-patients__section__image--mb"
              src="/assets/images/hpp-profile/chart3-mb.png"
              alt="HPP Profile"
            />
            <p class="hpp-patients__section__text-chart">
              Adults (≥18 years)<sup>7c</sup>
            </p>
          </div>
        </div>

        <p class="hpp-patients__section__content">
          Data from a multinational, noninterventional, retrospective chart
          review study designed to understand the natural history of 48 patients
          ≤5 years of age with severe perinatal- and infantile-onset HPP.
          Patients included in the study were those diagnosed with HPP based on
          at least one of the following: serum biomarker levels (below-normal
          ALP and above-normal PLP or phosphoethanolamine [PEA]), below-normal
          ALP and radiographic abnormalities, and/or genetic analysis of the
          ALPL gene. Additionally, onset of HPP must have occurred prior to 6
          months of age based on signs that included at least one of the
          following: respiratory compromise, rachitic chest deformity, and/or
          vitamin B<sub>6</sub>-responsive seizures.<sup>25</sup>
        </p>
      </div>
    </div>
  </div>

  <p
    class="wrapper hpp-patients__section__content--mb hpp-patients__section__content--a"
  >
    Data from a multinational, noninterventional, retrospective chart review
    study designed to understand the natural history of 48 patients ≤5 years of
    age with severe perinatal- and infantile-onset HPP. Patients included in the
    study were those diagnosed with HPP based on at least one of the following:
    serum biomarker levels (below-normal ALP and above-normal PLP or
    phosphoethanolamine [PEA]), below-normal ALP and radiographic abnormalities,
    and/or genetic analysis of the ALPL gene. Additionally, onset of HPP must
    have occurred prior to 6 months of age based on signs that included at least
    one of the following: respiratory compromise, rachitic chest deformity,
    and/or vitamin B<sub>6</sub>-responsive seizures.<sup>25</sup>
  </p>

  <p
    class="wrapper hpp-patients__section__content--mb hpp-patients__section__content--b"
  >
    Data from a retrospective, multinational, noninterventional natural history
    study of childhood HPP in patients 5 to 15 years of age (N=32).<sup>26</sup>
  </p>

  <p
    class="wrapper hpp-patients__section__content--mb hpp-patients__section__content--c"
  >
    Combined data from HIPS/HOST, an internet questionnaire and telephone survey
    that queried demographics, HPP-related illness history, disease progression,
    and health-related quality of life. One hundred twenty-five adults
    participated.<sup>7</sup>
  </p>

  <!-- HPP Patients notes -->

  <div class="hpp-patients__notes">
    <div class="hpp-patients__notes">
      <div class="hpp-patients__notes--red-string red-string"></div>

      <picture>
        <source
          media="(min-width: 768px)"
          srcset="/assets/images/hpp-profile/pin--desktop.png"
        />
        <img
          class="hpp-patients__notes--pin"
          src="/assets/images/hpp-profile/pin.png"
          alt="HPP patient note pin"
        />
      </picture>

      <p class="hpp-patients__notes--note">
        In a meta-analysis of pediatric patients with hypophosphatasia who were
        followed through adulthood [N=265], there was a <span
          class="hpp-patients__notes--note--text-red">high risk</span
        > of fractures (one or more, or multiple), gross motor/ambulatory difficulties,
        pain, and surgery with increasing age. <sup>27</sup>
        <br />
        <br />
        <span class="hpp-patients__notes--note--foot">
          Not all patients in this study were pediatric; 43 of the 265 patients
          had adult-onset HPP.
        </span>
      </p>
    </div>

    <div class="hpp-patients__percentage">
      <div class="hpp-patients__percentage--red-string red-string"></div>

      <picture>
        <source
          media="(min-width: 768px)"
          srcset="/assets/images/hpp-profile/pin--desktop.png"
        />
        <img
          class="hpp-patients__percentage--pin"
          src="/assets/images/hpp-profile/pin.png"
          alt="Pin"
        />
      </picture>

      <p class="hpp-patients__percentage--text text--center">94%</p>
      <p class="hpp-patients__percentage--content">
        of patients with at least 1 year of follow-up experienced at least 1
        manifestation or event that contributed to the <span
          class="hpp-patients__percentage--content--text-red"
          >clinical burden of hypophosphatasia.<sup>27</sup></span
        >
      </p>
      <p class="wrapper hpp-patients__percentage--disclaimer">
        *16.5% (43 patients/cases) had their first reported occurrence of HPP
        manifestations at 18 years of age or older.
      </p>
    </div>
  </div>

  <div class="wrapper hpp-patients__content">
    <h2 class="hpp__profile__title">
      WHY Hypophosphatasia SHOULD REMAIN ON YOUR RADAR
    </h2>
    <p class="hpp__profile__content">
      Though it has been previously classified as a rare disease, the overall
      prevalence of hypophosphatasia is unknown. Globally, hypophosphatasia
      affects males and females of all ages and appears to be especially
      prevalent in people of Caucasian descent.<sup>1,15,28,29</sup>
    </p>

    <div class="hpp-patients__red-frame-disclaimer">
      <p
        class="hpp-patients__red-frame-disclaimer--content color--white text--center"
      >
        While severe cases of hypophosphatasia occur in about 1:300,000 births,
        milder forms occur in about 1:6370 births. Additional affected
        individuals may be unrecognized or misdiagnosed.1,19-21
      </p>
    </div>

    <h2 class="hpp__profile__title">
      Proper diagnosis of hypophosphatasia is crucial
    </h2>
    <p class="hpp__profile__content">
      Misdiagnosing hypophosphatasia can put patients at risk, with some
      commonly used therapies prescribed for misdiagnoses negatively impacting
      their condition.18
    </p>
  </div>

  <CTA
    variation="variant-2"
    buttonLabel="Usual Suspects"
    content="Learn the risk of misdiagnosis"
    linkURL="#"
    bypassModal
  />
</section>
